You can now read 10 articles each month for free on BostonGlobe.com.

The Boston Globe

Business

Around the Region

Ironwood drug now available in US

Ironwood Pharmaceuticals Inc., of Cambridge, and Forest Laboratories Inc. said Monday that Ironwood’s new drug for irritable bowel syndrome with constipation is now available in the United States.

The drug is being marketed in the United States under the brand name Linzess. It was approved by the Food and Drug Administration earlier this year as a treatment for adults suffering from irritable bowel syndrome with constipation. Linzess is a trade name for linaclotide.

Loading comments...

You have reached the limit of 10 free articles a month

Stay informed with unlimited access to Boston’s trusted news source.

  • High-quality journalism from the region’s largest newsroom
  • Convenient access across all of your devices
  • Today’s Headlines daily newsletter
  • Subscriber-only access to exclusive offers, events, contests, eBooks, and more
  • Less than $1 a week